Fibrotic Interstitial Lung Disease Early Recognition and Strategic Therapy Study in China | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Fibrotic Interstitial Lung Disease Early Recognition and Strategic Therapy Study in China	interstitial lung disease, lung disorder, respiratory system disorder	Recruiting	Not stated	2024-10-23		NCT06655090

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Dai Huaping	1
Infervision Medical Technology Company Limited	1
Institute of Basic Medical Sciences CAMS	2
Jilin University	19
Nankai University	2
National Institute for Occupational Health and Poison Control	1
Shanghai Chest Hospital	116
Shanghai Pulmonary Hospital, Shanghai, China	98
The First Affiliated Hospital of Guangzhou Medical University	95
Tongji Hospital	276

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
China-Japan Friendship Hospital	Beijing	China	81